Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University, 386-390 [E9-31195]
Download as PDF
<![CDATA[
386
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
Dated: December 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31142 Filed 1–4–10; 8:45 am]
ACTION:
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0667]
[FDA 225–09–007]
Memorandum of Understanding
Between the United States Department
of Health and Human Services, Food
and Drug Administration, Center for
Drug Evaluation and Research and
Northeastern University
AGENCY:
Food and Drug Administration,
srobinson on DSKHWCL6B1PROD with PROPOSALS
HHS.
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
Notice.
DATES: The agreement became effective
November 19, 2009.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a Memorandum of
Understanding (MOU) between FDA
and Northeastern University. The
purpose of the MOU is to form a
collaborative relationship between FDA
and Northeastern University; provide
opportunities for exchanging of graduate
and undergraduate students, faculty,
and personnel and for advanced training
and outreach; stimulate cooperative
research, and information exchange in
biological product characterization and
regulation with Northeastern
University’s Barnett Institute of
Chemical and Biological Analysis; and
develop training programs for FDA and
potentially other Government agencies
and Industry in the broad areas of
biotechnology and analytical chemistry.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Keith O. Webber, Office of
Pharmaceutical Science, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD
20903, 301–796–2400, e-mail:
Keith.webber@fda.hhs.gov.
In
accordance with 21 CFR 20.108(c),
which states that all written agreements
and MOUs between FDA and others
shall be published in the Federal
Register, the agency is publishing notice
of this MOU.
SUPPLEMENTARY INFORMATION:
Dated: December 17, 2009.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
BILLING CODE 4160–01–S
E:\FR\FM\05JAN1.SGM
05JAN1
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4725
E:\FR\FM\05JAN1.SGM
05JAN1
387
EN05JA10.000</GPH>
srobinson on DSKHWCL6B1PROD with PROPOSALS
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
VerDate Nov<24>2008
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
16:41 Jan 04, 2010
Jkt 220001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4725
E:\FR\FM\05JAN1.SGM
05JAN1
EN05JA10.001</GPH>
srobinson on DSKHWCL6B1PROD with PROPOSALS
388
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4725
E:\FR\FM\05JAN1.SGM
05JAN1
389
EN05JA10.002</GPH>
srobinson on DSKHWCL6B1PROD with PROPOSALS
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
[FR Doc. E9–31195 Filed 1–4–10; 8:45 am]
BILLING CODE 4160–01–C
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\05JAN1.SGM
05JAN1
EN05JA10.003</GPH>
srobinson on DSKHWCL6B1PROD with PROPOSALS
390
]]>Agencies
[Federal Register Volume 75, Number 2 (Tuesday, January 5, 2010)]
[Notices]
[Pages 386-390]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-31195]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0667]
[FDA 225-09-007]
Memorandum of Understanding Between the United States Department
of Health and Human Services, Food and Drug Administration, Center for
Drug Evaluation and Research and Northeastern University
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
a Memorandum of Understanding (MOU) between FDA and Northeastern
University. The purpose of the MOU is to form a collaborative
relationship between FDA and Northeastern University; provide
opportunities for exchanging of graduate and undergraduate students,
faculty, and personnel and for advanced training and outreach;
stimulate cooperative research, and information exchange in biological
product characterization and regulation with Northeastern University's
Barnett Institute of Chemical and Biological Analysis; and develop
training programs for FDA and potentially other Government agencies and
Industry in the broad areas of biotechnology and analytical chemistry.
DATES: The agreement became effective November 19, 2009.
FOR FURTHER INFORMATION CONTACT: Keith O. Webber, Office of
Pharmaceutical Science, Center for Drug Evaluation and Research, Food
and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD
20903, 301-796-2400, e-mail: Keith.webber@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and MOUs between FDA and others
shall be published in the Federal Register, the agency is publishing
notice of this MOU.
Dated: December 17, 2009.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
BILLING CODE 4160-01-S
[[Page 387]]
[GRAPHIC] [TIFF OMITTED] TN05JA10.000
[[Page 388]]
[GRAPHIC] [TIFF OMITTED] TN05JA10.001
[[Page 389]]
[GRAPHIC] [TIFF OMITTED] TN05JA10.002
[[Page 390]]
[GRAPHIC] [TIFF OMITTED] TN05JA10.003
[FR Doc. E9-31195 Filed 1-4-10; 8:45 am]
BILLING CODE 4160-01-C
